Navigation Links
Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Date:6/7/2012

ar's technology has enabled seven approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia.

Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "expect," "believe," "should," "could," "potential," "may" and similar references to future periods.  Examples of forward-looking statements include our current views as to the potential of NKTR-181 as a new approach to opioid analgesia and pain therapy; the potential of NKTR-181 to be less attractive as a target of user abuse than standard opioid therapies; the potential of NKTR-181 to exhibit reduced CNS-related side effects associated with standard opioid therapies; our plans to initiate a Phase 2 clinical study for NKTR-181 in July 2012; the value of our polymer conjugate technology platform; and the potential of certain of our other drug candidates and those of our collaboration partners.  Forward-looking statements are neither historical facts nor assurances of future performance.  Instead, they are based only on our current beliefs, expectations, observations and assumptions regarding the potential of our drug candidates and our technology. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
2. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
3. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
4. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
5. ERT Announces Clearance from German Federal Cartel Office
6. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
7. American Oriental Bioengineering Inc. Announces Suspension of Trading in its Common Stock and the Initiation of Delisting Proceedings by NYSE
8. SIRO Clinpharm Announces a Fabulous Date With the Dueling Pianos
9. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
10. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
11. The Galien Foundation Announces New "Best Medical Technology" Award Category for 2012 Prix Galien USA Awards Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013  Grifols, a global healthcare ... presented results from a study demonstrating that a higher ... [Human]) increased levels of the alpha 1 protein ... levels that are considered within the normal range for ... in which low levels of the alpha 1 ...
(Date:5/22/2013)... 2013  Ohr Pharmaceutical Inc. (OTCQB: OHRP), a pharmaceutical ... unmet medical needs, today announced the appointment of ... its Board of Directors. Dr. Almenoff has extensive experience ... stage drug development. "We are delighted ... Irach Taraporewala, CEO of Ohr Pharmaceutical. "She offers tremendous ...
(Date:5/22/2013)... SALT LAKE CITY , May 22, 2013 ... VAR ) today announced it received 510(k) clearance ... for Varian,s diagnostic X-ray image processing workstation that ... capabilities on one platform.  Varian,s Nexus DRF Digital ... with a variety of image receptors, including CCD ...
Breaking Medicine Technology:Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2
... 4, 2011 Bioness Inc. today ... of the FASTEST study to further examine the impact of ... drop as a result of stroke. The FASTEST study aims ... System over standard therapy with an ankle-foot orthosis (AFO), and ...
... Inc. (NASDAQ: NBIX ) today announced that it ... for elagolix and next-generation Gonadotropin Releasing Hormone (GnRH) Receptor Antagonists. ... with the FDA, the outcome of which generated a $20 ... event brings the total milestones achieved by the Company in ...
Cached Medicine Technology:Bioness Inc. Announces Completion of Enrollment in Its FASTEST L300 Study 2Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement 2
(Date:5/22/2013)... next two decades, the cost of treating strokes in ... topping more than $180 billion a year, according to ... an aging population. The report, from the American Heart ... May 22 in the journal Stroke . ... Bruce Ovbiagele, chairman of the department of neurology at ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Award Presented ... Read the press release here: http://bit.ly/13DkFfk , ... was named “Information Management Product/Service of the Year” at ... March at The Colony Hotel in Palm Beach, Florida. ... virtual data room (VDR) solution that optimizes the ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Hurricane preparation ... your home. That’s why Amica Insurance is ... for the upcoming hurricane season. , “An important part ... Bryan Cook, a senior assistant vice president at Amica ... is before the threat of a storm.” , Flood ...
(Date:5/22/2013)... loving child care is one of the most important things ... in their search, Paty’s Daycare has launched a new ... and much more. , “Our new website is vibrant, fun ... “Auntie Paty” Sutton, founder of Paty’s Daycare. “Just as you ... the first time that you walk through the front door ...
(Date:5/22/2013)... 2013 Unknown to the citizens of Wichita, ... 30 mph. Minutes before it struck, the city’s warning siren ... This gave them time to reach safety and prevented any ... proud to provide a product that will increase safety in ... SAFEPATH® SP40S Emergency Evacuation System provides employees with the ...
Breaking Medicine News(10 mins):Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2Health News:Paty’s Daycare Launches New Website to Connect with Parents in Need of Nurturing Child Care 2Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2
... studies published in the current issue of Cell ... for treating diabetes. Researchers in Milan, Italy re-examine the ... and islet cell regeneration and Canadian researchers offer improved ... Both studies are in the current issue of ...
... HealthDay Reporter , THURSDAY, Feb. 17 (HealthDay News) -- ... the age of 2 arrive in emergency rooms with injuries ... shows. Most of these injuries involve cribs and are ... floor, said the researchers from Nationwide Children,s Hospital in Columbus, ...
... Feb. 17 (HealthDay News) -- Arthritis affected about 3.1 million ... there were wide variations in arthritis rates among Hispanic subgroups, ... of arthritis ranged from a low of 11.7 percent among ... Ricans, according to the analysis of National Health Interview Survey ...
... use does not appear to increase the risk of ... by University of Manchester scientists suggests. The researchers ... National Statistics to look at trends in rates of ... 2007. The study, published in the journal ...
... CHICAGOAfraid of becoming disabled in old age, not being able ... Staying physically active before symptoms set in could help. ... and taking overnight trips. According to research conducted at ... associated with a decreased risk of becoming disabled. The ...
... Institute and the University of Pennsylvania School of Medicine ... physicians with the first reliable blood test to predict ... 16 issue of the Journal of Proteome Research ... of clinical samples, published recently in the journal ...
Cached Medicine News:Health News:Researchers work at the frontiers of islet cell transplantation 2Health News:Researchers work at the frontiers of islet cell transplantation 3Health News:Crib Injuries Land Thousands of Toddlers in ER Each Year 2Health News:Crib Injuries Land Thousands of Toddlers in ER Each Year 3Health News:3.1 Million Hispanic Americans Struggle With Arthritis 2Health News:Cell-phone use not related to increased brain cancer risk 2Health News:Higher levels of social activity decrease the risk of developing disability in old age 2Health News:Biomarker discovery may lead to reliable blood test for ectopic pregnancy 2Health News:Biomarker discovery may lead to reliable blood test for ectopic pregnancy 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: